288 related articles for article (PubMed ID: 25130804)
1. [Expression of TFPI-2 gene and its promoter methylation in acute myeloid leukemia].
Shao LL; Fan J; Wang R; Feng LL; Zhen CQ; Sui XH; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):920-6. PubMed ID: 25130804
[TBL] [Abstract][Full Text] [Related]
2. Promoter of TFPI-2 is hypermethylated in Chinese pediatric acute myeloid leukemia.
Jian P; Yan WS; Chao SL; Liang P; Zhen L; Ling QB; Hong LY; Ping LY; Jian W; Fang JM; Ling L; Dong WX; Ming ZX; Jian N
J Pediatr Hematol Oncol; 2012 Jan; 34(1):43-6. PubMed ID: 22052167
[TBL] [Abstract][Full Text] [Related]
3. [ID4 promoter methylation in acute myeloid leukemia].
Xu RR; Liu F; Cui X; Zhang XW; Wang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):582-4. PubMed ID: 21729527
[TBL] [Abstract][Full Text] [Related]
4. [Promoter methylation status of hPer3 gene in AML patients and the in vitro effect of decitabine on the status].
Wang YK; Zhou JH; Zhou SQ; Fang GA; Li YW; Qiu L; Yang XC; Liu XG
Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):317-21. PubMed ID: 21729600
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of CpG sites at the promoter region is associated with deregulation of mitochondrial ATPsyn-β and chemoresistance in acute myeloid leukemia.
Yang J; Xiao X; Li R; Li Z; Deng M; Zhang G
Cancer Biomark; 2016; 16(1):81-8. PubMed ID: 26835708
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques.
Zawadzki C; Chatelain N; Delestre M; Susen S; Quesnel B; Juthier F; Jeanpierre E; Azzaoui R; Corseaux D; Breyne J; Torpier G; Staels B; Van Belle E; Jude B
Atherosclerosis; 2009 Jun; 204(2):e4-14. PubMed ID: 19081094
[TBL] [Abstract][Full Text] [Related]
7. [Detection of WT1 gene in acute myeloid leukemia children by real-time fluorescent quantitative RT-PCR and its clinical significance].
Zhang R; Sun HQ; Li G; Bai FY; Yang Y; Jing Q; Shi YJ; Yang JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):959-63. PubMed ID: 21867623
[TBL] [Abstract][Full Text] [Related]
8. [Methylation of Id4 gene promoter in acute leukemia].
Zhao Y; Wang QS; Dou LP; Bo J; Li HH; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1156-60. PubMed ID: 18088456
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
[TBL] [Abstract][Full Text] [Related]
10. [Expression of FANCG gene in acute myeloid leukemia].
Duan XL; Wang QL; Wang JG; Wang CY; Fan H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):7-11. PubMed ID: 23484681
[TBL] [Abstract][Full Text] [Related]
11. [Expression of death-associated protein kinase gene and methylation status of promoter region in acute leukemia].
Niu YM; Wang PP; Wang Y; Wang YZ; Cai DL; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):30-4. PubMed ID: 24598646
[TBL] [Abstract][Full Text] [Related]
12. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
[TBL] [Abstract][Full Text] [Related]
13. Methylation of CTNNA1 promoter: frequent but not an adverse prognostic factor in acute myeloid leukemia.
Chen XX; Lin J; Qian J; Qian W; Yang J; Ma JC; Deng ZQ; An C; Tang CY; Qian Z; Liu Q
Leuk Res; 2014 May; 38(5):613-8. PubMed ID: 24685333
[TBL] [Abstract][Full Text] [Related]
14. [Methylation Status and mRNA Expression of DKK-3 and WIF-1 in Acute Myeloid Leukemia Patients].
Xu MM; Yang YL; Geng YH; Li J; Ma Y; Zhang F; Zhu FB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1314-1320. PubMed ID: 29070101
[TBL] [Abstract][Full Text] [Related]
15. DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.
Zhou JD; Zhang TJ; Wang YX; Yang DQ; Yang L; Ma JC; Wen XM; Yang J; Lin J; Qian J
Tumour Biol; 2016 Jul; 37(7):8951-60. PubMed ID: 26753961
[TBL] [Abstract][Full Text] [Related]
16. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
Lian XY; Zhang W; Wu DH; Ma JC; Zhou JD; Zhang ZH; Wen XM; Xu ZJ; Lin J; Qian J
J Cell Physiol; 2018 Dec; 233(12):9584-9593. PubMed ID: 30132837
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of ITGBL1 is associated with poor prognosis in acute myeloid leukemia.
Lian XY; Ma JC; Zhou JD; Zhang TJ; Wu DH; Deng ZQ; Zhang ZH; Li XX; He PF; Yan Y; Lin J; Qian J
J Cell Physiol; 2019 Jun; 234(6):9438-9446. PubMed ID: 30317626
[TBL] [Abstract][Full Text] [Related]
18. [PRAME mRNA expression in newly diagnosed acute myeloid leukemia patients and its application to monitoring minimal residual disease].
Qin YZ; Li JL; Zhu HH; Li LD; Chang Y; Hao L; Wang YZ; Jiang B; Lu XJ; Liu YR; Huang XJ; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):441-5. PubMed ID: 19035174
[TBL] [Abstract][Full Text] [Related]
19. [Significance of DNA methylation status of runx3 gene promoter region in acute leukemia].
Lin DJ; Fan RF; Liu XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):263-6. PubMed ID: 18426645
[TBL] [Abstract][Full Text] [Related]
20. [Significance of id4 promoter methylation in monitoring AML patients with completely remission].
Zhao Y; Wang QS; Li HH; Bo J; Dou LP; Jing Y; Wang SH; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):476-8. PubMed ID: 18549611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]